• 2358 Citations
  • 30 h-Index
20002019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Samantha Galluzzi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Alzheimer Disease Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Atrophy Medicine & Life Sciences
Dementia Medicine & Life Sciences
Brain Medicine & Life Sciences
Cerebrospinal Fluid Medicine & Life Sciences
Amyloid Medicine & Life Sciences
Cognitive Dysfunction Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

  • 2358 Citations
  • 30 h-Index
  • 82 Article
  • 2 Review article
  • 1 Short survey
1 Citation (Scopus)

Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study

Alzheimer's Disease Neuroimaging Initiative, Nov 1 2019, In : The Lancet Neurology. 18, 11, p. 1034-1044 11 p.

Research output: Contribution to journalArticle

Biomarkers
Dementia
Tauopathies
Alzheimer Disease
Amyloid

Biomarker matrix to track short term disease progression in amnestic mild cognitive impairment patients with prodromal Alzheimer's disease

Marizzoni, M., Ferrari, C., Macis, A., Jovicich, J., Albani, D., Babiloni, C., Cavaliere, L., Didic, M., Forloni, G., Galluzzi, S., Hoffmann, K. T., Molinuevo, J. L., Nobili, F., Parnetti, L., Payoux, P., Pizzini, F., Rossini, P. M., Salvatore, M., Schönknecht, P., Soricelli, A. & 10 others, Del Percio, C., Hensch, T., Hegerl, U., Tsolaki, M., Visser, P. J., Wiltfang, J., Richardson, J. C., Bordet, R., Blin, O. & Frisoni, G. B., Jan 1 2019, In : Journal of Alzheimer's Disease. 69, 1, p. 49-58 10 p.

Research output: Contribution to journalArticle

Sample Size
Cerebrospinal Fluid
Disease Progression
Parahippocampal Gyrus
Alzheimer Disease

Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease

Brugnolo, A., De Carli, F., Pagani, M., Morbelli, S., Jonsson, C., Chincarini, A., Frisoni, G. B., Galluzzi, S., Perneczky, R., Drzezga, A., Van Berckel, B. N. M., Ossenkoppele, R., Didic, M., Guedj, E., Arnaldi, D., Massa, F., Grazzini, M., Pardini, M., Mecocci, P., Dottorini, M. E. & 3 others, Bauckneht, M., Sambuceti, G. & Nobili, F., Jan 1 2019, In : Journal of Alzheimer's Disease. 68, 1, p. 383-394 12 p.

Research output: Contribution to journalArticle

Alzheimer Disease
Brain
Healthy Volunteers
ROC Curve
Area Under Curve
3 Citations (Scopus)

Plasma Aβ 42 as a biomarker of prodromal Alzheimer's disease progression in patients with amnestic mild cognitive impairment: Evidence from the PharmaCog/E-ADNI Study

Albani, D., Marizzoni, M., Ferrari, C., Fusco, F., Boeri, L., Raimondi, I., Jovicich, J., Babiloni, C., Soricelli, A., Lizio, R., Galluzzi, S., Cavaliere, L., Didic, M., Schönknecht, P., Molinuevo, J. L., Nobili, F., Parnetti, L., Payoux, P., Bocchio, L., Salvatore, M. & 9 others, Rossini, P. M., Tsolaki, M., Visser, P. J., Richardson, J. C., Wiltfang, J., Bordet, R., Blin, O., Forloni, G. & Frisoni, G. B., Jan 1 2019, In : Journal of Alzheimer's Disease. 69, 1, p. 37-48 12 p.

Research output: Contribution to journalArticle

Open Access
Clusterin
Disease Progression
Alzheimer Disease
Biomarkers
Prodromal Symptoms
1 Citation (Scopus)

Predicting and tracking short term disease progression in amnestic mild cognitive impairment patients with prodromal Alzheimer's disease: Structural brain biomarkers

Marizzoni, M., Ferrari, C., Jovicich, J., Albani, D., Babiloni, C., Cavaliere, L., Didic, M., Forloni, G., Galluzzi, S., Hoffmann, K. T., Molinuevo, J. L., Nobili, F., Parnetti, L., Payoux, P., Ribaldi, F., Rossini, P. M., Schönknecht, P., Salvatore, M., Soricelli, A., Hensch, T. & 7 others, Tsolaki, M., Visser, P. J., Wiltfang, J., Richardson, J. C., Bordet, R., Blin, O. & Frisoni, G. B., Jan 1 2019, In : Journal of Alzheimer's Disease. 69, 1, p. 3-14 12 p.

Research output: Contribution to journalArticle

Disease Progression
Alzheimer Disease
Biomarkers
Brain
Sample Size